Goldman Sachs’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9M Sell
439,101
-232,777
-35% -$7.82M ﹤0.01% 2912
2025
Q4
$28.8M Sell
671,878
-65,157
-9% -$2.46M ﹤0.01% 2024
2025
Q3
$20.9M Buy
737,035
+554,786
+304% +$16.6M ﹤0.01% 2225
2025
Q2
$3.41M Buy
182,249
+122,775
+206% +$2.33M ﹤0.01% 3768
2025
Q1
$1.07M Sell
59,474
-107,461
-64% -$2.18M ﹤0.01% 4637
2024
Q4
$2.81M Buy
166,935
+120,822
+262% +$2.32M ﹤0.01% 4001
2024
Q3
$746K Buy
+46,113
New +$542K ﹤0.01% 4831
2024
Q2
Sell
-40,948
Closed -$606K 5876
2024
Q1
$606K Sell
40,948
-10,226
-20% -$138K ﹤0.01% 4649
2023
Q4
$742K Sell
51,174
-7,348
-13% -$75.1K ﹤0.01% 4553
2023
Q3
$632K Buy
58,522
+7,158
+14% +$86.1K ﹤0.01% 4532
2023
Q2
$663K Buy
51,364
+2,081
+4% +$28.1K ﹤0.01% 4585
2023
Q1
$651K Buy
49,283
+8,695
+21% +$138K ﹤0.01% 4676
2022
Q4
$609K Sell
40,588
-201,803
-83% -$1.85M ﹤0.01% 4756
2022
Q3
$2.86M Buy
242,391
+48,599
+25% +$657K ﹤0.01% 3648
2022
Q2
$2.19M Buy
193,792
+131,125
+209% +$2.63M ﹤0.01% 3966
2022
Q1
$1.87M Sell
62,667
-115,665
-65% -$3.13M ﹤0.01% 4323
2021
Q4
$4.73M Sell
178,332
-56,997
-24% -$1.72M ﹤0.01% 3466
2021
Q3
$8.54M Buy
235,329
+36,987
+19% +$1.46M ﹤0.01% 2873
2021
Q2
$8.61M Buy
198,342
+37,487
+23% +$1.42M ﹤0.01% 2837
2021
Q1
$5.5M Sell
160,855
-129,587
-45% -$5.13M ﹤0.01% 3048
2020
Q4
$10.2M Buy
290,442
+197,168
+211% +$5.71M ﹤0.01% 2452
2020
Q3
$2.24M Buy
93,274
+60,599
+185% +$1.49M ﹤0.01% 3482
2020
Q2
$598K Sell
32,675
-189,905
-85% -$3.42M ﹤0.01% 4275
2020
Q1
$3.47M Sell
222,580
-88,828
-29% -$1.89M ﹤0.01% 2922
2019
Q4
$6.66M Buy
311,408
+21,287
+7% +$438K ﹤0.01% 2741
2019
Q3
$5.42M Buy
290,121
+75,176
+35% +$1.55M ﹤0.01% 2800
2019
Q2
$5.61M Sell
214,945
-3,930
-2% -$88.7K ﹤0.01% 2764
2019
Q1
$5.63M Sell
218,875
-193,412
-47% -$4.42M ﹤0.01% 2878
2018
Q4
$9.48M Buy
412,287
+201,730
+96% +$5.69M ﹤0.01% 2384
2018
Q3
$6.76M Buy
210,557
+12,234
+6% +$367K ﹤0.01% 2757
2018
Q2
$5.61M Buy
198,323
+147,310
+289% +$5.24M ﹤0.01% 2881
2018
Q1
$1.81M Buy
51,013
+4,109
+9% +$164K ﹤0.01% 3676
2017
Q4
$1.82M Buy
46,904
+28,123
+150% +$1.07M ﹤0.01% 3868
2017
Q3
$477K Buy
18,781
+319
+2% +$7.76K ﹤0.01% 5125
2017
Q2
$504K Sell
18,462
-638
-3% -$17.5K ﹤0.01% 5094
2017
Q1
$632K Sell
19,100
-42,481
-69% -$1.08M ﹤0.01% 4802
2016
Q4
$1.47M Sell
61,581
-115,228
-65% -$3.3M ﹤0.01% 4131
2016
Q3
$6.49M Buy
176,809
+165,785
+1,504% +$4.75M ﹤0.01% 2817
2016
Q2
$246K Buy
11,024
+2,834
+35% +$70.5K ﹤0.01% 5519
2016
Q1
$170K Buy
8,190
+2,254
+38% +$55.6K ﹤0.01% 5743
2015
Q4
$180K Buy
5,936
+1,716
+41% +$52K ﹤0.01% 5785
2015
Q3
$104K Sell
4,220
-3,980
-49% -$119K ﹤0.01% 6459
2015
Q2
$263K Sell
8,200
-3,998
-33% -$153K ﹤0.01% 5875
2015
Q1
$435K Sell
12,198
-11,240
-48% -$308K ﹤0.01% 5277
2014
Q4
$532K Buy
23,438
+13,837
+144% +$280K ﹤0.01% 5224
2014
Q3
$187K Sell
9,601
-6,924
-42% -$196K ﹤0.01% 6217
2014
Q2
$600K Sell
16,525
-5,565
-25% -$189K ﹤0.01% 5154
2014
Q1
$857K Buy
22,090
+3,597
+19% +$128K ﹤0.01% 4830
2013
Q4
$527K Sell
18,493
-15,829
-46% -$465K ﹤0.01% 5259
2013
Q3
$1.23M Buy
34,322
+24,989
+268% +$912K ﹤0.01% 4412
2013
Q2
$312K Buy
+9,333
New +$423K ﹤0.01% 5305

Other funds holding RIGL